SomnoMed Limited
SOMNF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 7.6% | 15.4% | 3.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 58.2% | 61.6% | 52% | 54.6% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -2.6% | 5.7% | -3.5% | -2.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5.8% | -0.2% | -12.7% | -14.1% |
| EPS Diluted | -0.016 | -0.001 | -0.049 | -0.053 |
| % Growth | -1,644.4% | 98.2% | 7% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |